Staar Surgical Co (STAA) concluded trading on Wednesday at a closing price of $16.48, with 8.29 million shares of worth about $136.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.24% during that period and on February 12, 2025 the price saw a loss of about -24.68%. Currently the company’s common shares owned by public are about 49.28M shares, out of which, 48.93M shares are available for trading.
Stock saw a price change of -30.26% in past 5 days and over the past one month there was a price change of -26.69%. Year-to-date (YTD), STAA shares are showing a performance of -32.15% which decreased to -45.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $21.13 but also hit the highest price of $52.68 during that period. The average intraday trading volume for Staar Surgical Co shares is 606.87K. The stock is currently trading -28.07% below its 20-day simple moving average (SMA20), while that difference is down -31.46% for SMA50 and it goes to -51.04% lower than SMA200.
Staar Surgical Co (NASDAQ: STAA) currently have 49.28M outstanding shares and institutions hold larger chunk of about 100.80% of that.
The stock has a current market capitalization of $812.07M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$0.41 in the same period. It has Quick Ratio of 4.62 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STAA, volatility over the week remained 8.73% while standing at 5.36% over the month.
Stock’s fiscal year EPS is expected to drop by -270.95% while it is estimated to increase by 155.09% in next year.
Coverage by Mizuho stated Staar Surgical Co (STAA) stock as a Neutral in their note to investors on February 13, 2025, suggesting a price target of $17 for the stock. Stock get an Underweight rating from Morgan Stanley on July 15, 2024.
